NU SKIN ENTERPRISES, INC. Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NU SKIN ENTERPRISES, INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2026-06-30 was $1.12M, a 80.80% decline year-over-year.
- NU SKIN ENTERPRISES, INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2026-03-31 was $3.69M, a 13.10% increase year-over-year.
- NU SKIN ENTERPRISES, INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2025-12-31 was $3.81M, a 10.60% increase year-over-year.
- NU SKIN ENTERPRISES, INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2025-09-30 was $5.82M, a 66.73% increase year-over-year.
- NU SKIN ENTERPRISES, INC. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2025 was $18.71M, a 26.25% increase from fiscal 2024.
- NU SKIN ENTERPRISES, INC. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2024 was $14.82M, a 5.26% decline from fiscal 2023.
- NU SKIN ENTERPRISES, INC. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2023 was $15.65M, a 26.51% increase from fiscal 2022.
- NU SKIN ENTERPRISES, INC. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2022 was $12.37M, a 46.68% decline from fiscal 2021.
| Period end | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 3 month | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 12 month |
|---|---|---|
| 2026-06-30 | $1.12M 10-Q · filed 2026-08-10 | $14.44M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $3.69M 10-Q · filed 2026-05-08 | $19.14M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $3.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $18.71M 10-K · filed 2026-02-13 |
| 2025-09-30 | $5.82M 10-Q · filed 2025-11-07 | $18.35M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $5.82M 10-Q · filed 2026-08-10 | $16.02M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $3.27M 10-Q · filed 2026-05-08 | $13.85M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $3.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $14.82M 10-K · filed 2026-02-13 |
| 2024-09-30 | $3.49M 10-Q · filed 2025-11-07 | $14.50M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $3.65M 10-Q · filed 2025-08-08 | $14.73M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $4.24M 10-Q · filed 2025-05-09 | $15.89M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $3.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $15.65M 10-K · filed 2026-02-13 |
| 2023-09-30 | $3.73M 10-Q · filed 2024-11-08 | $15.57M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | $4.80M 10-Q · filed 2024-08-09 | $15.02M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | $4.00M 10-Q · filed 2024-05-09 | $12.24M derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | $3.05M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $12.37M 10-K · filed 2025-02-14 |
| 2022-09-30 | $3.17M 10-Q · filed 2023-11-02 | $16.04M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | $2.02M 10-Q · filed 2023-08-02 | $15.96M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | $4.13M 10-Q · filed 2023-05-04 | $20.52M derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | $6.72M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $23.19M 10-K · filed 2024-02-15 |
| 2021-09-30 | $3.09M 10-Q · filed 2022-11-03 | $25.10M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $6.58M 10-Q · filed 2022-08-05 | $29.12M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $6.80M 10-Q · filed 2022-05-05 | $27.41M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $8.62M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $24.06M 10-K · filed 2023-02-16 |
| 2020-09-30 | $7.12M 10-Q · filed 2021-11-04 | $15.70M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $4.87M 10-Q · filed 2021-08-05 | $9.60M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | $3.46M 10-Q · filed 2021-05-05 | $8.32M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $260.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $9.91M 10-K · filed 2022-02-16 |
| 2019-09-30 | $1.01M 10-Q · filed 2020-11-05 | $15.95M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-06-30 | $3.59M 10-Q · filed 2020-08-06 | $21.98M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-03-31 | $5.04M 10-Q · filed 2020-05-07 | $24.89M derived: sum of 4 quarters · filed 2021-02-11 |
| 2018-12-31 | $6.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $26.61M 10-K · filed 2021-02-11 |
| 2018-09-30 | $7.04M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $6.51M 10-Q · filed 2019-08-07 | |
| 2018-03-31 | $6.76M 10-Q · filed 2019-05-01 | |
| 2017-12-31 | $19.31M 10-K · filed 2020-02-13 | |
| 2016-12-31 | $8.89M 10-K · filed 2019-02-14 | |
| 2015-12-31 | $7.40M 10-K · filed 2018-02-16 | |
| 2014-12-31 | $17.50M 10-K · filed 2017-02-27 | |
| 2013-12-31 | $32.62M 10-K · filed 2016-02-18 | |
| 2012-12-31 | $21.36M 10-K · filed 2015-03-02 | |
| 2011-12-31 | $15.10M 10-K · filed 2014-03-18 | |
| 2010-12-31 | $10.84M 10-K · filed 2013-02-27 | |
| 2009-12-31 | $9.99M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B | |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |